Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
320,506
-
Share change
-
-153,287
-
Total reported value
-
$90,350
-
Price per share
-
$0.28
-
Number of holders
-
12
-
Value change
-
-$66,189
-
Number of buys
-
6
-
Number of sells
-
9
Institutional Holders of KIROMIC BIOPHARMA INC - COM (KRBP) as of Q3 2022
As of 30 Sep 2022,
KIROMIC BIOPHARMA INC - COM (KRBP) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
320,506 shares.
The largest 10 holders included
ZEKE CAPITAL ADVISORS, LLC, Redmond Asset Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, UBS Group AG, STATE STREET CORP, StoneX Group Inc., TWO SIGMA SECURITIES, LLC, Cetera Advisor Networks LLC, and WealthTrust Axiom LLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.